373 related articles for article (PubMed ID: 19215820)
1. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
[TBL] [Abstract][Full Text] [Related]
2. Limitations of dynamic contrast-enhanced MRI in monitoring radiation-induced changes in the fraction of radiobiologically hypoxic cells in human melanoma xenografts.
Benjaminsen IC; Melås EA; Mathiesen BS; Rofstad EK
J Magn Reson Imaging; 2008 Nov; 28(5):1209-18. PubMed ID: 18972344
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
Gulliksrud K; Brurberg KG; Rofstad EK
Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
[TBL] [Abstract][Full Text] [Related]
7. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
[TBL] [Abstract][Full Text] [Related]
8. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions.
Gaustad JV; Benjaminsen IC; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2007 Jul; 26(1):133-43. PubMed ID: 17659570
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced-MRI of tumor hypoxia.
Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Magn Reson Med; 2012 Feb; 67(2):519-30. PubMed ID: 21661044
[TBL] [Abstract][Full Text] [Related]
11. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
[TBL] [Abstract][Full Text] [Related]
13. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
[TBL] [Abstract][Full Text] [Related]
14. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
Ellingsen C; Ovrebø KM; Galappathi K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1317-23. PubMed ID: 22270159
[TBL] [Abstract][Full Text] [Related]
15. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: pharmacokinetic analysis and correlation to tumor histomorphology.
Ellingsen C; Egeland TA; Galappathi K; Rofstad EK
Radiother Oncol; 2010 Nov; 97(2):217-24. PubMed ID: 20656365
[TBL] [Abstract][Full Text] [Related]
17. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.
Egeland TA; Gaustad JV; Vestvik IK; Benjaminsen IC; Mathiesen B; Rofstad EK
Magn Reson Med; 2006 Apr; 55(4):874-82. PubMed ID: 16506163
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
Rofstad EK; Sundfør K; Lyng H; Tropé CG
Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
20. Capillary permeability and extracellular volume fraction in uterine cervical cancer as patient outcome predictors: measurements by using dynamic MRI spin-lattice relaxometry.
Dedieu V; Bailly C; Vincent C; Achard JL; Le Bouedec G; Penault-Llorca F; Verrelle P; Vincensini D
J Magn Reson Imaging; 2008 Apr; 27(4):846-53. PubMed ID: 18383262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
